Glucagon analogue

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameGlucagon analogue
Drug Alias NameG-530-LNN-9030NNC9204-0530
ClassificationBiologics
Mechanisms of ActionGlucagon receptor agonists
TargetsGlucagon receptor
Therapy Area/IndicationsObesityNutritional and Metabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsObesityNutritional and Metabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A